Implementation of Pharmacogenomics in Molecular Tumor Boards

Implementation of Pharmacogenomics in Molecular Tumor Boards

Beate Jahn (ORCID: 0000-0002-6764-6362)

Disciplines

Health Sciences (30%); Computer Sciences (20%); Clinical Medicine (25%); Medical Biotechnology (25%)

Keywords

    PGx diagnostics, Molecular Tumor Boards, Health Technology Assessment, Cancer Therapy, Benefit-Harm Analysis

Research institution(s)